- Scope of application
- Type of organisation
- Public administration
- Organisation responsible
- Ministry of Health (MZ)
According to the Slovenian "Regulations on labeling and instructions for use of medicinal products for human use" the name of the medicinal product must be written on the packaging in Braille, except for medicinal products for clinical trials and for medicinal products administered by medical professionals with an "H" or "ZZ" dispensing regime in accordance with the regulation on the classification, prescribing and dispensing of medicinal products for use in human medicine. If there is a drug in several different strengths, the name of the drug must also be followed by the strength.
The Braille labeling mandate is indicative of Slovenia's commitment to creating an inclusive healthcare environment for its visually impaired population. Furthermore, while the rule is comprehensive, it wisely excludes certain categories like clinical trial medications and those administered directly by healthcare professionals, striking a balance between accessibility and practical considerations.
Disclaimer: Accessible EU is not responsible for the accessibility of content provided by third parties.